Company Overview and News

133
GNC Third Quarter 2018 Earnings Release, Webcast and Conference Call Scheduled for October 31, 2018

2018-10-12 globenewswire
PITTSBURGH, Oct. 12, 2018 (GLOBE NEWSWIRE) -- GNC Holdings, Inc. (NYSE: GNC), a leading specialty health, wellness, and performance retailer, will release results for the third quarter of 2018 before the market opens on October 31, 2018. A webcast and conference call to discuss the results will be held at 8:30 am Eastern Time that day.
RAD GNC

1
GNC Holdings E-Commerce Business Solid, Competition Rife

2018-10-09 zacks
On Oct 8, we issued an updated research report on GNC Holdings, Inc. (GNC - Free Report) . We are upbeat about this Zacks Rank #3 (Hold) company’s significant progress with e-commerce business over the last few quarters. However, cut-throat competition continues to be a concern.
MASI GNC AMED ISRG

2
GNC Holdings: What's Next Post CFIUS Approval?

2018-09-14 seekingalpha - 2
The big downside risk has been removed and the shorts, collectively short 26.5 million shares as of August 31, 2018, are heading towards the exit.
GNC

7
GNC / GNC Holdings, Inc. 8-K CFIUS APPROVAL (Current Report)

2018-09-13 sec.gov - 7
Document UNITED STATES
GNC

13
GNC: An Increasingly Dangerous Short

2018-09-08 seekingalpha - 3
GNC’s share price has declined greatly over the last few years as the business has deteriorated and risks multiplied in the face of generally negative sentiment on retail.
GNC VSI

307
Stocks To Watch: Time To Talk Valuation

2018-09-01 seekingalpha - 9
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
HIBB JWN DKS AVGO APRN PCB SODA AMC TMUS PDYPF AKCA JONE COUP SOLO REV MESA CZR LJPC VZ HEAR FCAU BRC MGM GCO FB ULTA IGT TM IRBT VCNX CTXR LB GMVHF MTCH DBX KS JNEEP AAPL USAK TSG ZAGG PRTY KSU DDS MRVL COOL HMC GBX TSCO DSKE MU DG WRK BYD LOW LRCX TXN CTRP TWX HA SKYW GNC RCL RH UAL PFCF AMZN TWTR CATO BKS VLKAY OSTK AAL BKE BBY GWRE MDLZ GME ON NSC NAV GOOGL QCOM HD XLNX CHDN CPB WDAY FND JBLU QSII WIMHY ALK ADBE MDXG GM GOGO CROX DAL CWH WIMHF F TECH PANW COST M SAVE WMH W S PEP URBN

11
GNC / GNC Holdings, Inc. 8-K (Current Report)

2018-08-28 sec.gov - 11
Document UNITED STATES
GNC

3
I Got 43% Return On My Obesity-Themed Portfolio. Janus Henderson Investors Did Better With SLIM.

2018-08-27 seekingalpha
I most often pull from my toolbox a program to weight candidates in potential portfolios so as have that portfolio fall on the Efficient Frontier (EF).
SLIM ANGO NVO GNC FINL

11
Vitamin Shoppe: Cognitive Dissonance And Why We Got Short When Shares Crossed $11

2018-08-11 seekingalpha - 1
Vitamin Shoppe's stock is on a tear after posting better than feared Q2 2018 results, but this just feels like a short squeeze.
GNC VSI MS

60
Time to Take Profits in Vitamin Shoppe Stock

2018-08-11 investorplace - 1
After a dismal 2017, retailers have mostly rallied in 2018, and Vitamin Shoppe (NYSE:VSI) has been one of the biggest winners. VSI stock has gained over 150% just since early April. An activist effort, two straight quarters of “good enough” earnings, and likely some short-covering have driven the rally.
GS AMZN AEO VSI GNC ANF URBN

21
Goldman Puts Money Behind Vitamin Startup Valued Close to GNC - Bloomberg

2018-08-07 bloomberg - 2
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GSC TFG GNC GSJ BRK.A GS GLSSP AAPL VSI GJS

2
Is GNC Holdings (GNC) a Great Stock for Value Investors?

2018-08-07 zacks - 2
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
GNC

122
7 High Short-Interest Stocks

2018-08-06 investorplace - 5
Short selling seems unsavory. It is betting that a company’s stock will drop, after all. However, many of the world’s top investors engage in this activity — George Soros, Paul Tudor Jones and John Paulson just to name a few. Short positions are required to be disclosed to the public. This is what gives us short interest. High-short interest stocks are stocks with a higher than usual amount of short interest.
APRN ENT GNC ENTWW VZA SHLD VSAT KR AMZN FTRPR GRUB TSLA VZ GOGO FTR

 
GNC / GNC Holdings, Inc. 8-K (Current Report)

2018-08-03 sec.gov
Document UNITED STATES
GNC

12
GNC Holdings: Bring A Knife To A Gun Fight

2018-07-30 seekingalpha - 2
On July 26, 2017, GNC beat Q2 2018 Adjusted EBITDA estimates by 18%, yet its stock barely moved that day.
VSI GNC MS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to GNC / GNC Holdings, Inc. on message board site Silicon Investor.

GNCP , NMGL GNCP , NMGL GNCP , NMGL SANGUINE CORP. (SGNC) SANGUINE CORP. (SGNC) SANGUINE CORP. (SGNC)
SGNC Sanguine Corp. Info Thread SGNC Sanguine Corp. Info Thread SGNC Sanguine Corp. Info Thread TTLN + GGNC + SNMM + CRY.TO pioneers of internet TTLN + GGNC + SNMM + CRY.TO pioneers of internet TTLN + GGNC + SNMM + CRY.TO pioneers of internet
Organic, Inc. (OGNC) Organic, Inc. (OGNC) Organic, Inc. (OGNC) General Communication, Inc. GNCMA General Communication, Inc. GNCMA General Communication, Inc. GNCMA
GGNC - GIC/Global Intertainment Corporation GGNC - GIC/Global Intertainment Corporation GGNC - GIC/Global Intertainment Corporation GNCI General Nutrition GNCI General Nutrition GNCI General Nutrition
GGNC: A Rothschildian Perspective GGNC: A Rothschildian Perspective GGNC: A Rothschildian Perspective General Communications Cl A (GNCMA) General Communications Cl A (GNCMA) General Communications Cl A (GNCMA)
CUSIP: 36191G107